Novartis announced that it has selected Salesforce’s Agentforce Life Sciences platform to drive personalized customer engagement across marketing, sales, patient services, medical, and market‑access functions. The partnership will deploy Agentforce 360 for Life Sciences, a unified, agentic AI solution that integrates structured and unstructured health data, provides a conversational interface, and is built on Salesforce’s Einstein Trust Layer to meet HIPAA and other regulatory requirements.
The deal builds on Novartis’s existing investment in Salesforce products. The company already uses Agentforce Health, Data 360 for Health & Life Sciences, MuleSoft for Life Sciences, and Agentforce Marketing. By adding Agentforce 360, Novartis will be able to automate routine interactions with healthcare professionals and patients, generate real‑time insights from disparate data sources, and scale its engagement programs across global markets.
For Salesforce, the agreement marks a significant expansion of its life‑sciences portfolio. Novartis is a high‑margin, global pharmaceutical leader, and the partnership positions Salesforce as a key partner in a sector that is increasingly adopting AI‑powered CRM solutions. The deal also demonstrates the company’s ability to monetize its AI platform in a new vertical, reinforcing its broader strategy to grow revenue from high‑margin, subscription‑based services.
The partnership occurs in a competitive landscape where other CRM and AI vendors—such as Veeva Systems, Medallia, and SAP—also target life‑sciences customers. By securing Novartis, Salesforce gains a marquee client that can serve as a reference for future life‑sciences engagements and helps differentiate its platform through deep integration with health‑specific data and compliance features.
Frank Defesche, General Manager of Life Sciences at Salesforce, said the collaboration “underscores our commitment to transforming how the life sciences industry engages with marketing, sales, and medical stakeholders. By unifying engagement, we are providing the foundation for more personal, accurate, and connected experiences that help bring the right therapies to patients who need them.”
revised_sentiment_rating
importance
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.